Amnon Gat
Vermögen: 1 Mio $ am 30.09.2026
Vermögen: 1 Mio $ am 30.09.2026
Amnon Gat currently works at Alpha Tau Medical Ltd., as Chief Operating Officer from 2018.
Mr. Gat also formerly worked at Alpha Tau Medical, as Director from 2019 to 2021 and Brainsway Ltd., as Vice President-Marketing.
Mr. Gat received his undergraduate degree from The Open University of Israel, Masters Business Admin degree from The Interdisciplinary Center Herzliya, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALPHA TAU MEDICAL LTD 0,07 % | 01.03.2026 | 68.475 ( 0,07 % ) | 1 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALPHA TAU MEDICAL LTD. | Geschäftsführer | 01.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
Alpha Tau Medical | Direktor/Vorstandsmitglied | 01.01.2021 |
| BRAINSWAY LTD. | Vertrieb & Marketing | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
The Open University of Israel
The Open University of Israel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brainsway Ltd.
Brainsway Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets deep transcranial magnetic stimluation systems, novel, noninvasive medical devices | Health Technology |
The Interdisciplinary Center Herzliya
The Interdisciplinary Center Herzliya Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. Medical SpecialtiesHealth Technology Specializes in research, development and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer | Health Technology |
Alpha Tau Medical |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen